Amgen (AMGN) Q4 Earnings Top, Horizon Drugs Drive Sales

Amgen (AMGN) reported fourth-quarter 2023 adjusted earnings of $4.71 per share, which beat the Zacks Consensus Estimate of$4.66. Earnings rose 15% year over year on higher revenues, which were partially offset by higher operating costs and higher interest expenses.Total revenues of $8.2 billion marginally beat the Zacks Consensus Estimate of$8.16 billion. Total revenues rose 20% year over year, driven by higher product sales.Total product revenues increased 20% from the year-ago quarter to $7.83 billion ( ...